Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics where W. Christopher Ehmann is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Cytotoxic lymphocytes induced by engineered human dendritic cells mediate potent anti-leukemia activity
Zhao, C., Jia, B., Jiang, Y., Shike, H., Annageldiyev, C., Cioccio, J., Minagawa, K., Mineishi, S., Ehmann, W., Schell, T. D., Cheng, H. & Zheng, H., Mar 2025, In: Cancer Immunology, Immunotherapy. 74, 4, 117.Research output: Contribution to journal › Article › peer-review
Open Access1 Link opens in a new tab Scopus citations -
Prior status of graft-versus-host disease affects donor lymphocyte infusion outcomes in patients with relapsed haematological malignancies after allogeneic stem cell transplantation
Velasco, C. M., Inoue, Y., Cioccio, J., Rakszawski, K., Songdej, N., Nickolich, M., Zheng, H., Naik, S., Ehmann, C., Mierski, J., Silar, B., Vajdic, C., Greiner, R., Brown, V., Mineishi, S., Shike, H. & Minagawa, K., Aug 2025, In: British Journal of Haematology. 207, 2, p. 515-524 10 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Safety and feasibility of intermediate-dose post-transplant cyclophosphamide for graft-versus-host disease prophylaxis
Venugopal, N., McGowan, A., Inoue, Y., Zheng, H., Cioccio, J., Rakszawski, K., Songdej, N., Nickolich, M., Naik, S., Ehmann, C., Sivik, J., Mierski, J., Silar, B., Vajdic, C., Shike, H., Mineishi, S. & Minagawa, K., Dec 2025, In: Annals of Hematology. 104, 12, p. 6451-6462 12 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Link opens in a new tab Scopus citations -
A phase I study using bortezomib (Velcade), cladribine, and rituximab in treating patients over 50 years old with mantle cell lymphoma
Pu, J. J., Berger, K. N., Zheng, C., Do, N., Claxton, D. F., Ehmann, W. C., Drabick, J. J., Li, H., Loughran, T. P. & Epner, E. M., 2024, In: Frontiers in Oncology. 14, 1449401.Research output: Contribution to journal › Article › peer-review
Open Access -
Impact of post-transplant cyclophosphamide and splenomegaly on primary graft failure and multi-lineage cytopenia after allogeneic hematopoietic cell transplantation
Zulch, E., Inoue, Y., Cioccio, J., Rakszawski, K., Songdej, N., Nickolich, M., Zheng, H., Naik, S., Rybka, W., Ehmann, C., Sivik, J., Mierski, J., Silar, B., Vajdic, C., Greiner, R., Brown, V., Hohl, R., Claxton, D., Shike, H. & Paules, C. I. & 2 others, , Aug 2024, In: Leukemia Research. 143, 107530.Research output: Contribution to journal › Article › peer-review
Open Access3 Link opens in a new tab Scopus citations